Molbio Diagnostics raises around ₹281 crore from anchor investors ahead of its initial public offering, according to multiple reports. The issue is priced with a price band of ₹768 to ₹807 per share, and public subscription is scheduled to open on August 10 and close on August 12.
The company plans to raise about ₹904 crore to ₹940 crore through the public issue. Sources say proceeds are intended for infrastructure upgrades and the purchase of new equipment for its manufacturing facilities. In addition to anchor participation, current shareholders are expected to sell part of their stakes as part of the IPO process.
While the reports broadly align on the amount raised from anchor investors and the key dates for subscription, they differ on the exact timing of the share listing. Business Line does not mention the debut date, while Economic Times says the shares are set to list on August 17.
